These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 31206846

  • 1. The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
    van Zyl A, Schubert PT, Koegelenberg CFN.
    Cytopathology; 2019 Nov; 30(6):586-591. PubMed ID: 31206846
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Utility of TTF-1 and Napsin-A in the work-up of malignant effusions.
    El Hag M, Schmidt L, Roh M, Michael CW.
    Diagn Cytopathol; 2016 Apr; 44(4):299-304. PubMed ID: 26799356
    [Abstract] [Full Text] [Related]

  • 6. Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases.
    Gurda GT, Zhang L, Wang Y, Chen L, Geddes S, Cho WC, Askin F, Gabrielson E, Li QK.
    Clin Transl Med; 2015 Apr; 4():16. PubMed ID: 25977750
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
    Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J.
    Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962
    [Abstract] [Full Text] [Related]

  • 8. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
    Argon A, Nart D, Veral A.
    Turk Patoloji Derg; 2015 Feb; 31(2):81-8. PubMed ID: 25944390
    [Abstract] [Full Text] [Related]

  • 9. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.
    Noh S, Shim H.
    Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.
    Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL.
    Mod Pathol; 2011 Oct; 24(10):1348-59. PubMed ID: 21623384
    [Abstract] [Full Text] [Related]

  • 11. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ, Shin HC, Shin KC, Ro JY.
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [Abstract] [Full Text] [Related]

  • 12. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
    Tran L, Mattsson JS, Nodin B, Jönsson P, Planck M, Jirström K, Botling J, Micke P, Brunnström H.
    Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895
    [Abstract] [Full Text] [Related]

  • 13. Double staining: diagnostic utility in non-small cell lung carcinoma in the era of tissue conservation.
    Hosny Mohammed K, Ewaz A, Cohen C, Siddiqui MT.
    J Am Soc Cytopathol; 2017 Oct; 6(4):170-175. PubMed ID: 31043270
    [Abstract] [Full Text] [Related]

  • 14. [Expression of TTF-1, NapsinA, P63, CK5/6 in Lung Cancer and Its Diagnostic Values for Histological Classification].
    Yu H, Li L, Liu D, Li WM.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 May; 48(3):336-341. PubMed ID: 28616902
    [Abstract] [Full Text] [Related]

  • 15. The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma.
    Roh MH, Schmidt L, Placido J, Farmen S, Fields KL, Courey AJ, Arenberg DA, Knoepp SM.
    Diagn Cytopathol; 2012 Nov; 40(11):949-55. PubMed ID: 21500373
    [Abstract] [Full Text] [Related]

  • 16. ΔNp63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens.
    Zhao W, Wang H, Peng Y, Tian B, Peng L, Zhang DC.
    Int J Clin Exp Pathol; 2014 Nov; 7(7):4247-53. PubMed ID: 25120805
    [Abstract] [Full Text] [Related]

  • 17. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
    Khayyata S, Yun S, Pasha T, Jian B, McGrath C, Yu G, Gupta P, Baloch Z.
    Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
    [Abstract] [Full Text] [Related]

  • 18. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
    Kawai T, Tominaga S, Hiroi S, Kameda K, Ogata S, Nakashima H, Ozeki Y, Nakanishi K.
    Acta Cytol; 2015 Mar; 59(6):457-64. PubMed ID: 26696549
    [Abstract] [Full Text] [Related]

  • 19. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
    Nishino M, Hoang MP, Della Pelle P, Morales-Oyarvide V, Huynh TG, Mark EJ, Mino-Kenudson M.
    Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
    [Abstract] [Full Text] [Related]

  • 20. Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies.
    Warth A, Muley T, Herpel E, Meister M, Herth FJ, Schirmacher P, Weichert W, Hoffmann H, Schnabel PA.
    Histopathology; 2012 Dec; 61(6):1017-25. PubMed ID: 22882703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.